Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells

Favipiravir (T-705), used against influenza viruses, is approved for emergency use in many countries for the treatment of COVID-19. The frequent adverse effects of favipiravir are related with the gastrointestinal system, however, studies suggest a positive association of favipiravir on QTc prolonga...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunaydin-Akyildiz, Aysenur, Aksoy, Nergis, Boran, Tugce, Ilhan, Emine Nihan, Ozhan, Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492396/
https://www.ncbi.nlm.nih.gov/pubmed/36152797
http://dx.doi.org/10.1016/j.toxlet.2022.09.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492396/
https://www.ncbi.nlm.nih.gov/pubmed/36152797
http://dx.doi.org/10.1016/j.toxlet.2022.09.011

Ejemplares similares